Schonfeld Strategic Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,200	Closed	-$285K	–	1575
2019 Q3	$285K	Sell	4,200 -9,000	-68%	-$618K	0.01%	796
2019 Q2	$768K	Buy	13,200 +500	+4%	+$29.6K	0.03%	515
2019 Q1	$890K	Sell	12,700 -3,400	-21%	-$252K	0.03%	533
2018 Q4	$1.04M	Buy	+16,100	New	+$1.13M	0.04%	473

Schonfeld Strategic Advisors's GHDX Position: Q4 2019 in Review

Schonfeld Strategic Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 4,200 shares — an estimated $285K sold.

Schonfeld Strategic Advisors first reported a position in GHDX in Q4 2018 and held it in 4 quarters. The position peaked at $1.04M in Q4 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Schonfeld Strategic Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Schonfeld Strategic Advisors sold 4,200 Genomic Health, Inc. shares in Q4 2019, an estimated $285K.
Schonfeld Strategic Advisors first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 4 quarters.
Schonfeld Strategic Advisors's Genomic Health, Inc. position peaked at $1.04M in Q4 2018.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.